Loading organizations...
Key people at Pulse 4 Pulse.
Pulse 4 Pulse provides onsite diagnostic cardiovascular wellness testing services directly to medical practices. The company offers a comprehensive, turnkey solution that enables healthcare providers to integrate proactive cardiovascular diagnostics into their existing operations. This approach focuses on improving patient care through the early detection of conditions such as Peripheral Artery Disease (PAD) within the convenience of a clinical setting.
Established around 2020, Pulse 4 Pulse was founded to address the critical need for accessible and early diagnostic testing in cardiovascular health. The founders recognized that equipping medical practices with specialized diagnostic tools could significantly enhance patient outcomes by identifying potential issues before they escalate. This insight led to the development of a service designed to streamline the implementation of advanced diagnostic capabilities for clinics.
The company's clientele primarily consists of medical practices seeking to expand their diagnostic offerings and improve patient care pathways. Pulse 4 Pulse aims to empower these practices with the means to conduct essential cardiovascular screenings, thereby contributing to a more preventative healthcare model. Its long-term vision centers on fostering proactive health management through widespread access to sophisticated, yet easy-to-implement, diagnostic services.
Pulse4Pulse is a healthcare services company based in Waterbury, Connecticut, specializing in onsite diagnostic testing of the cardiovascular and autonomic nervous system to enable early detection of chronic diseases in asymptomatic patients.[1][2][6] It offers an all-in-one service—including FDA-cleared portable medical devices, onsite certified medical technicians, immediate physician reports, and full-service billing—targeting physicians' practices to shift healthcare from reactive to proactive, focusing on the microvascular system for personalized early interventions.[1][2][3][8] With under 25 employees and revenue below $5 million, it has raised limited funding (under $5M total) and emphasizes Medicare-approved tests that 60% of patients qualify for, up to three times yearly, to improve patient care, diagnose complex symptoms, and boost treatment compliance.[1][6]
Pulse4Pulse LLC was incorporated on July 12, 2017, as a limited liability company in Connecticut, with Ms. Krista Mowad serving as President and principal contact.[4] The company emerged to address gaps in proactive healthcare, pioneering diagnostic testing for the microvascular system to detect issues before they escalate, driven by a belief in Early Detection Medicine (EDM) as key to successful treatment.[1][8] Early traction includes building an onsite service model with portable tech and billing support, evolving from a medical billing focus to comprehensive diagnostics, as reflected in its BBB profile and operational setup by 2020.[4] Employee reviews highlight rapid growth, with roles like certified medical assistants noting easy training, independent workflows, and supportive remote management amid high-pressure events.[5]
Pulse4Pulse rides the trend toward preventive healthcare and Early Detection Medicine, leveraging portable, FDA-cleared diagnostics amid rising demand for non-invasive chronic disease screening in primary care.[1][2][8] Timing aligns with post-pandemic emphasis on proactive models, microvascular insights for conditions like diabetes or hypertension, and Medicare reimbursement incentives that favor early interventions over costly late-stage treatments.[6] Market forces include aging populations, value-based care shifts, and tech portability enabling onsite use in small practices; it influences the ecosystem by empowering physicians with actionable data, reducing invasive procedures, and standardizing asymptomatic screenings as envisioned in its mission.[1][8]
Pulse4Pulse is positioned to expand its onsite model as preventive diagnostics gain traction, potentially scaling through partnerships with larger networks or tech integrations for broader asymptomatic screening adoption.[1][2] Trends like AI-enhanced reporting, telehealth synergies, and expanded insurance coverage for microvascular tests could accelerate growth, while workforce scaling (e.g., more technicians at ~$22/hour) supports demand.[5][7] Its influence may evolve from niche provider to standard in physician practices, reinforcing the paradigm shift to EDM—empowering early insights that started with its microvascular focus.[8]
Key people at Pulse 4 Pulse.
